Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Melanie C. Dispenza

The Bruton’s Tyrosine Kinase Inhibitor Acalabrutinib Protects From Anaphylaxis in a Humanized Mouse Model

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Dendritic Cell Immunization Route Determines Integrin Expression and Lymphoid and Nonlymphoid Tissue Distribution of CD8 T Cells

Journal of Immunology
AllergyImmunology
2007English

Related publications

Combined Inhibition of Bruton’s Tyrosine Kinase (BTK) and Phosphoinositide 3-Kinase (PI3K) P110δ Improves Monocytosis and Splenomegaly in a JMML Mouse Model

Proceedings of IMPRS
2018English

Tyrosine Kinase Inhibitor NVP-BGJ398 Functionally Improves FGFR3-related Dwarfism in Mouse Model

Journal of Clinical Investigation
Medicine
2016English

A Specific Inhibitor for Tyrosine Protein Kinase From Pseudomonas.

Journal of Antibiotics
Drug DiscoveryPharmacology
1986English

Correction To: Role of Bruton’s Tyrosine Kinase in B Cells and Malignancies

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2019English

Switch-Like Activation of Bruton’s Tyrosine Kinase by Membrane-Mediated Dimerization

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Webinar | Humanized Mouse Models in Checkpoint Inhibitor Development

Science
MultidisciplinaryPhilosophy of ScienceHistory
2017English

Development of a Pharmacodynamic Assay Based on PLCγ2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)–Bruton’s Tyrosine Kinase (BTK) Signaling

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2013English

Randomized Phase II Study of the Bruton Tyrosine Kinase Inhibitor Acalabrutinib, Alone or With Pembrolizumab in Patients With Advanced Pancreatic Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Bruton’s Tyrosine Kinase Is at the Crossroads of Metabolic Adaptation in Primary Malignant Human Lymphocytes

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy